CHOP Research Team Redefines the Footprint of Viral Vector Gene Therapy

Building on a track record of developing adeno-associated viral (AAV) vectors as a groundbreaking clinical tool for gene therapy and gene editing, Children’s Hospital of Philadelphia (CHOP) researchers report a more sensitive method for capturing the footprint of AAV vectors–a broad range of sites where the vectors transfer genetic material.

Source link

Related posts

Secondhand Smoke Exposure as Kids Tied to Women’s Arthritis


Birth Weight Linked to Mental Health Later in Life


Chemically Detoxified Versus Recombinant Pertussis Toxin Vaccines


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World